In order to clarify the role and mechanism of DS more deeply, we introduced BRU, an inhibitor of Nrf2, to further investigate the regulation and effect of DS on Nrf2/HO-1 signaling pathway. The gene discussed is NFE2L2; the disease is Dravet syndrome.